0 Comments
0 Shares
116 Views
0 Reviews
Search
Discover new people, create new connections and make new friends
-
Please log in to like, share and comment!
-
Oncology Imaging Software Market: Insights and Competitive Analysis 2025 –2032According to the latest report published by Data Bridge Market Research, the Oncology Imaging Software Market CAGR Value The global Oncology Imaging Software Market size was valued at USD 4.44 billion in 2025 and is expected to reach USD 6.80 billion by 2033, at a CAGR of 5.5% during the forecast period The Oncology Imaging Software...0 Comments 0 Shares 104 Views 0 Reviews
-
Oncology Information Systems Market: Insights and Competitive Analysis 2025 –2032According to the latest report published by Data Bridge Market Research, the Oncology Information Systems Market CAGR Value Global Oncology Information Systems Market is increasing at a CAGR of 7.90%. Our detailed analysis forecasts that the market is valued at USD 4.30 billion in 2023 and is expected to grow upto USD 7.91 billion by 2031. This Oncology Information...0 Comments 0 Shares 113 Views 0 Reviews
-
(R)-N-Boc-3-(Aminomethyl)Pyrrolidine Market 2026–2034: Chiral Pharmaceutical Intermediates Driving CNS, Oncology, and Antiviral Drug Development(R)-N-Boc-3-(Aminomethyl)Pyrrolidine market was valued at USD 28.4 million in 2025 and is projected to reach USD 58.2 million by 2034, exhibiting a remarkable CAGR of 7.4% during the forecast period. (R)-N-Boc-3-(Aminomethyl)Pyrrolidine is a specialized chiral pyrrolidine derivative featuring a tert-butoxycarbonyl (Boc) protecting group and an aminomethyl substituent at the 3-position....0 Comments 0 Shares 367 Views 0 Reviews
-
Advancements in Immuno-Oncology: The Future of Keytruda Market AnalysisAs we move through 2026, the oncology landscape is witnessing a transformative era, with pembrolizumab continuing to set the benchmark for cancer care. The Keytruda Market analysis reveals that the drug’s ability to treat over 40 indications—ranging from non-small cell lung cancer to advanced melanoma—has solidified its position as a global blockbuster. In 2026, the...0 Comments 0 Shares 367 Views 0 Reviews
-
AI in Oncology Market: How AI Is Enhancing Medical Imaging for Cancer DetectionPolaris Market Research today announced findings from its latest report, projecting the global AI in Oncology market to grow from USD 6.51 billion in 2025 to USD 56.44 billion by 2034, at a CAGR of 27.1%. The report profiles 10 leading companies across multiple market segments, benchmarking the global AI in oncology landscape across component, application, and regional lines. The market covers...0 Comments 0 Shares 131 Views 0 Reviews
-
AI In Oncology Market: How Partnerships and Acquisitions Are Redrawing the MapAI In Oncology Market Overview The AI in oncology market was valued at USD 6.0 billion in 2025. It is estimated at USD 8.3 billion in 2026 and is projected to reach USD 38.9 billion by 2033, a CAGR of 24.8% from 2026 to 2033. That is roughly a 4.7x expansion in seven years, and it signals that AI is becoming a core layer of cancer care rather than an experimental add-on. North America led in...0 Comments 0 Shares 105 Views 0 Reviews
-
AI In Oncology Market: How Precision Medicine Is Reshaping GrowthCancer diagnosis used to hinge almost entirely on the trained eye of a radiologist or pathologist, working scan by scan, slide by slide. That model is now being layered — not replaced, but sharpened — by algorithms that can flag a suspicious lesion in milliseconds or predict a chemotherapy dose from a CT scan's fat, bone, and muscle composition. That shift is exactly what's fueling...0 Comments 0 Shares 200 Views 0 Reviews
-
Anthracycline-Based Oncology Drug Class Market"Executive Summary Anthracycline-Based Oncology Drug Class Market Size and Share Forecast CAGR Value Anthracycline-Based Oncology Drug Class Market research report brings into focus the key market dynamics of the sector. The Anthracycline-Based Oncology Drug Class Market study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities, challenges,...0 Comments 0 Shares 240 Views 0 Reviews
-
Anti-Neoplastic Agents Market Opportunities 2034: Biotechnology and Oncology Drug DiscoveryCompetition in the anti-neoplastic agents market is shaped by research capabilities, clinical development pipelines, product differentiation, and regulatory expertise. Pharmaceutical companies invest in novel compounds, biologic therapies, and expanded indications for established medicines. Long-term competitiveness depends on clinical evidence, treatment suitability, manufacturing reliability,...0 Comments 0 Shares 184 Views 0 Reviews
-
Anti-Neoplastic Agents Market: Precision Oncology and Advanced Treatment Trends to 2034The Anti-Neoplastic Agents Market is undergoing significant transformation as pharmaceutical innovation, advances in oncology, and increasing cancer prevalence drive demand for effective therapeutic solutions. Anti-neoplastic agents encompass medicines used to prevent, inhibit, or control the growth and spread of cancer cells. The evolving oncology landscape is encouraging pharmaceutical...0 Comments 0 Shares 181 Views 0 Reviews
-
Anticancer Drugs Market to Surpass $303.1 Billion by 2031 as Precision Oncology and Immunotherapy Revolutionize Cancer CareThe global industry was valued at US$ 140.2 Bn in 2022 and is estimated to grow at a CAGR of 9.1% from 2023 to 2031, reaching US$ 303.1 Bn by the end of 2031. The anticancer drugs market is witnessing substantial expansion as the global burden of cancer continues to rise and healthcare systems increasingly prioritize advanced oncology treatments. The growing prevalence of various forms of...0 Comments 0 Shares 416 Views 0 Reviews
-
Cancer Biomarker Innovation Reshapes Diagnostic and Treatment StrategiesThe cancer biomarkers market is entering a period of strong expansion as rising cancer cases, increasing emphasis on early diagnosis, and growing adoption of personalized treatment continue to reshape oncology care. According to Grand View Research, the market size was valued at USD 26.9 billion in 2025 and is projected to increase from USD 29.9 billion in 2026 to USD 65.3 billion by 2033,...0 Comments 0 Shares 401 Views 0 Reviews
-
Cancer Care Enters a New Digital Era as AI Adoption Continues to ExpandThe AI in oncology market is entering a rapid expansion phase as healthcare providers, researchers, and pharmaceutical companies increasingly use artificial intelligence to improve cancer diagnostics, treatment planning, and research. The market was valued at USD 6.0 billion in 2025 and is projected to grow from USD 8.3 billion in 2026 to USD 38.9 billion by 2033, registering a CAGR of 24.8%...0 Comments 0 Shares 320 Views 0 Reviews
-
Chemotherapy at Home Services Market: Growth & Forecast 2034Chemotherapy at Home Services Market: Growth, Trends, Demand & Forecast to 2034 Chemotherapy at Home Services Market Snapshot The Chemotherapy at Home Services Market is emerging as an important segment of decentralized cancer care, supported by the growing demand for convenient treatment options, advances in home healthcare infrastructure, and increasing interest in...0 Comments 0 Shares 709 Views 0 Reviews
-
Companion Diagnostics Oncology MarketCompanion Diagnostics Oncology Market to Reach USD 12.31 Billion by 2034 as Precision Cancer Care Expands According to a report published by OG Analysis, the Companion Diagnostics Oncology Market is valued at USD 5.11 billion in 2026 and is projected to reach USD 12.31 billion by 2034, growing at a CAGR of 11.61%. Increasing biomarker-guided cancer treatment, targeted therapies and advanced...0 Comments 0 Shares 97 Views 0 Reviews
-
Decoding the Future: Oncology Drugs Market Growth Dynamics and 2026 ProjectionsAs we move through 2026, the global fight against cancer has entered a phase of unprecedented acceleration. The Oncology Drugs Market Growth Dynamics are currently defined by a "precision-first" approach, where the traditional boundaries between chemotherapy and immunotherapy are blurring. Market valuation is now surging toward the $210 billion mark, fueled by the rapid clinical...0 Comments 0 Shares 337 Views 0 Reviews
-
Digital Pathology Solutions for Oncology Market Revenue Forecast - 2032According to the latest report published by Data Bridge Market Research, the Digital Pathology Solutions for Oncology Market size is projected to grow from USD 960.60 Million in 2024 to USD 2,000.85 Million by 2032, exhibiting a CAGR of 9.60% during the forecast period 2025 - 2032. Digital Pathology Solutions for Oncology Market is the world-class market research report which...0 Comments 0 Shares 73 Views 0 Reviews
-
First-in-Class Oncology Drug market Size, Share, Trends, Key Drivers, Demand and Opportunity Analysis"First-in-Class Oncology Drug Market Summary: According to the latest report published by Data Bridge Market Research, the First-in-Class Oncology Drug Market The global first-in-class oncology drug market size was valued at USD 8.67 billion in 2025 and is expected to reach USD 25.08 billion by 2033, at a CAGR of14.20% during the forecast periodThe market growth is largely fueled by...0 Comments 0 Shares 221 Views 0 Reviews
-
Global Immuno Oncology Drugs Market Fueled by Precision Medicine and Targeted TherapiesAdvancements in monoclonal antibody technologies are strengthening the development of immuno-oncology treatments. Continuous improvements in antibody engineering are supporting innovative approaches to cancer management. Market Overview The Immuno-Oncology Drugs Market size was valued at US$ 77.80 billion in 2024 and is expected to reach US$ 237.73 billion by 2031. The market is...0 Comments 0 Shares 34 Views 0 Reviews
More Results